Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey(*)

BACKGROUND: Registry data suggest that people with immune‐mediated inflammatory diseases (IMIDs) receiving targeted systemic therapies have fewer adverse coronavirus disease 2019 (COVID‐19) outcomes compared with patients receiving no systemic treatments. OBJECTIVES: We used international patient su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahil, S.K., Yates, M., Langan, S.M., Yiu, Z.Z.N., Tsakok, T., Dand, N., Mason, K.J., McAteer, H., Meynell, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Bruce, I.N., Capon, F., Contreras, C.R., Cope, A.P., De La Cruz, C., Di Meglio, P., Gisondi, P., Hyrich, K., Jullien, D., Lambert, J., Marzo‐Ortega, H., McInnes, I., Naldi, L., Norton, S., Puig, L., Sengupta, R., Spuls, P., Torres, T., Warren, R.B., Waweru, H., Weinman, J., Griffiths, C.E.M., Barker, J.N., Brown, M.A., Galloway, J.B., Smith, C.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214088/
https://www.ncbi.nlm.nih.gov/pubmed/33368145
http://dx.doi.org/10.1111/bjd.19755

Ejemplares similares

Ejemplares similares